» Articles » PMID: 38093743

Protective Effect of Ticagrelor Against Infective Endocarditis Induced by Virulent in Mice

Abstract

In addition to its potent antiplatelet activity, ticagrelor possesses antibacterial properties against gram-positive bacteria. We wondered whether the typical clinical dosage of ticagrelor could prevent the development of infective endocarditis caused by highly virulent . Ticagrelor prevented vegetation formation in a mouse model of inflammation-induced endocarditis. The dosage achieved in patients under ticagrelor therapy altered bacterial toxin production and adherence on activated endothelial cells, thereby mitigating bacterial virulence. Besides the previously described bactericidal activity at high doses, ticagrelor at typical clinical doses possesses antivirulence activity against . Ticagrelor antiplatelet activity further interferes with the interplay between platelets and bacteria.

Citing Articles

Ticagrelor Antibiotic Effect: Ready for Exploring Clinical Implementation?.

Martinez-Selles H, Martinez-Selles M JACC Basic Transl Sci. 2023; 8(11):1454-1456.

PMID: 38093740 PMC: 10714169. DOI: 10.1016/j.jacbts.2023.03.020.


Machine Learning with Alpha Toxin Phenotype to Predict Clinical Outcome in Patients with Bloodstream Infection.

Beadell B, Nehra S, Gusenov E, Huse H, Wong-Beringer A Toxins (Basel). 2023; 15(7).

PMID: 37505686 PMC: 10467129. DOI: 10.3390/toxins15070417.

References
1.
Prasannan N, Scully M . Novel antiplatelet strategies targeting VWF and GPIb. Platelets. 2020; 32(1):42-46. DOI: 10.1080/09537104.2020.1786038. View

2.
Wallentin L, Becker R, Budaj A, Cannon C, Emanuelsson H, Held C . Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2009; 361(11):1045-57. DOI: 10.1056/NEJMoa0904327. View

3.
Ulloa E, Uchiyama S, Gillespie R, Nizet V, Sakoulas G . Ticagrelor Increases Platelet-Mediated Staphylococcus aureus Killing, Resulting in Clearance of Bacteremia. J Infect Dis. 2021; 224(9):1566-1569. PMC: 8599881. DOI: 10.1093/infdis/jiab146. View

4.
Karer M, Rager-Resch M, Haider T, Petroczi K, Gludovacz E, Borth N . Diamine oxidase knockout mice are not hypersensitive to orally or subcutaneously administered histamine. Inflamm Res. 2022; 71(4):497-511. PMC: 8989821. DOI: 10.1007/s00011-022-01558-2. View

5.
Xiong Y, Van Wamel W, Nast C, Yeaman M, Cheung A, Bayer A . Activation and transcriptional interaction between agr RNAII and RNAIII in Staphylococcus aureus in vitro and in an experimental endocarditis model. J Infect Dis. 2002; 186(5):668-77. DOI: 10.1086/342046. View